OXiGENE, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
E Is OxiGene The Cheapest Biotech On The Nasdaq?
Article By: Small Cap Gems
Tuesday, March 31, 2015 11:40 AM EDT
OxiGene, a small and virtually unknown biotech stock on the Nasdaq, boasts an impressive pipeline, yet the stock now trades at exactly cash level after a major sell-off. With multiple near-term catalysts in sight, I think shares could rebound hard.
In this article: OXGN
E OXiGENE: First Patient Enrolled In Phase 1b/2 Study Of Fosbretabulin
Article By: Trevor Lowenthal
Wednesday, October 8, 2014 12:04 PM EDT
OXiGENE announces that the first patient has been enrolled in the Phase 1b/2 study of fosbretabulin in combination with Votrient(TM) (pazopanib) in patients with recurrent ovarian cancer.
In this article: OXGN


Latest Tweets for $OXGN

No tweets yet!


Is OxiGene The Cheapest Biotech On The Nasdaq?
Dick Kaplan 4/1/2015 2:26:30 AM

$OXGN looks very promising, thanks.

1 to 1 of 1 comments